William Blair & Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.69M | Sell |
8,454
-20
| -0.2% | -$3.96K | ﹤0.01% | 781 |
|
|
2025
Q4 | $1.6M | Buy |
8,474
+88
| +1% | +$16.9K | ﹤0.01% | 803 |
|
|
2025
Q3 | $1.49M | Buy |
8,386
+685
| +9% | +$102K | ﹤0.01% | 813 |
|
|
2025
Q2 | $875K | Sell |
7,701
-1,533
| -17% | -$164K | ﹤0.01% | 935 |
|
|
2025
Q1 | $971K | Sell |
9,234
-14
| -0.2% | -$1.58K | ﹤0.01% | 894 |
|
|
2024
Q4 | $991K | Buy |
9,248
+33
| +0.4% | +$3.73K | ﹤0.01% | 908 |
|
|
2024
Q3 | $922K | Buy |
9,215
+80
| +0.9% | +$8.05K | ﹤0.01% | 924 |
|
|
2024
Q2 | $770K | Sell |
9,135
-10
| -0.1% | -$796 | ﹤0.01% | 961 |
|
|
2024
Q1 | $669K | Sell |
9,145
-11
| -0.1% | -$811 | ﹤0.01% | 1006 |
|
|
2023
Q4 | $654K | Sell |
9,156
-975
| -10% | -$57.5K | ﹤0.01% | 996 |
|
|
2023
Q3 | $607K | Hold |
10,131
| – | – | ﹤0.01% | 1000 |
|
|
2023
Q2 | $730K | Sell |
10,131
-95
| -0.9% | -$7.13K | ﹤0.01% | 944 |
|
|
2023
Q1 | $752K | Sell |
10,226
-5
| -0% | -$355 | ﹤0.01% | 910 |
|
|
2022
Q4 | $683K | Sell |
10,231
-6,169
| -38% | -$401K | ﹤0.01% | 949 |
|
|
2022
Q3 | $881K | Sell |
16,400
-48
| -0.3% | -$2.82K | ﹤0.01% | 855 |
|
|
2022
Q2 | $915K | Sell |
16,448
-3,274
| -17% | -$186K | ﹤0.01% | 875 |
|
|
2022
Q1 | $1.38M | Sell |
19,722
-4,357
| -18% | -$316K | ﹤0.01% | 806 |
|
|
2021
Q4 | $2.32M | Buy |
24,079
+167
| +0.7% | +$15.4K | 0.01% | 690 |
|
|
2021
Q3 | $2.08M | Buy |
23,912
+460
| +2% | +$35.6K | 0.01% | 697 |
|
|
2021
Q2 | $1.92M | Sell |
23,452
-22,963
| -49% | -$1.91M | 0.01% | 719 |
|
|
2021
Q1 | $4.41M | Sell |
46,415
-5,432
| -10% | -$513K | 0.02% | 476 |
|
|
2020
Q4 | $3.22M | Buy |
51,847
+12,771
| +33% | +$728K | 0.01% | 537 |
|
|
2020
Q3 | $2.32M | Buy |
39,076
+4,640
| +13% | +$317K | 0.01% | 551 |
|
|
2020
Q2 | $2.4M | Sell |
34,436
-1,599
| -4% | -$101K | 0.01% | 517 |
|
|
2020
Q1 | $1.64M | Sell |
36,035
-10,171
| -22% | -$576K | 0.01% | 558 |
|
|
2019
Q4 | $3.01M | Buy |
46,206
+426
| +0.9% | +$28.5K | 0.02% | 513 |
|
|
2019
Q3 | $2.84M | Sell |
45,780
-82,248
| -64% | -$5.16M | 0.02% | 494 |
|
|
2019
Q2 | $9.12M | Sell |
128,028
-17,104
| -12% | -$1.26M | 0.05% | 278 |
|
|
2019
Q1 | $11.4M | Sell |
145,132
-88,414
| -38% | -$6.7M | 0.07% | 239 |
|
|
2018
Q4 | $19.8M | Buy |
233,546
+17,314
| +8% | +$1.85M | 0.14% | 151 |
|
|
2018
Q3 | $37M | Sell |
216,232
-5,075
| -2% | -$765K | 0.23% | 107 |
|
|
2018
Q2 | $28.6M | Buy |
221,307
+9,365
| +4% | +$1.05M | 0.19% | 122 |
|
|
2018
Q1 | $21.8M | Buy |
211,942
+15,728
| +8% | +$1.56M | 0.15% | 138 |
|
|
2017
Q4 | $16.8M | Sell |
196,214
-3,031
| -2% | -$263K | 0.11% | 183 |
|
|
2017
Q3 | $16.9M | Sell |
199,245
-8,467
| -4% | -$670K | 0.13% | 173 |
|
|
2017
Q2 | $15.7M | Buy |
207,712
+2,555
| +1% | +$179K | 0.12% | 187 |
|
|
2017
Q1 | $13.5M | Buy |
205,157
+21,343
| +12% | +$1.4M | 0.11% | 195 |
|
|
2016
Q4 | $11.7M | Buy |
183,814
+46,825
| +34% | +$2.95M | 0.1% | 201 |
|
|
2016
Q3 | $8.72M | Buy |
136,989
+27,948
| +26% | +$2.05M | 0.08% | 232 |
|
|
2016
Q2 | $8.11M | Buy |
109,041
+5,413
| +5% | +$402K | 0.08% | 228 |
|
|
2016
Q1 | $6.92M | Buy |
103,628
+5,053
| +5% | +$307K | 0.07% | 237 |
|
|
2015
Q4 | $6.67M | Sell |
98,575
-119,393
| -55% | -$7.37M | 0.06% | 248 |
|
|
2015
Q3 | $11.6M | Sell |
217,968
-2,141,076
| -91% | -$130M | 0.1% | 210 |
|
|
2015
Q2 | $148M | Buy |
2,359,044
+18,707
| +0.8% | +$1.02M | 0.22% | 134 |
|
|
2015
Q1 | $113M | Buy |
2,340,337
+472,779
| +25% | +$18.1M | 0.17% | 179 |
|
|
2014
Q4 | $62M | Buy |
1,867,558
+175,878
| +10% | +$5.72M | 0.1% | 276 |
|
|
2014
Q3 | $49.6M | Buy |
1,691,680
+339,211
| +25% | +$11.3M | 0.08% | 312 |
|
|
2014
Q2 | $52.6M | Sell |
1,352,469
-149,015
| -10% | -$6.05M | 0.09% | 315 |
|
|
2014
Q1 | $63M | Sell |
1,501,484
-415,677
| -22% | -$17.3M | 0.1% | 275 |
|
|
2013
Q4 | $62.9M | Buy |
1,917,161
+1,570,804
| +454% | +$51.2M | 0.1% | 289 |
|
|
2013
Q3 | $9.35M | Buy |
+346,357
| New | +$9.74M | 0.02% | 761 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
William Blair & Company's LGND Position: Q1 2026 in Review
William Blair & Company reduced its Ligand Pharmaceuticals (LGND) stake by 0.24% in Q1 2026, selling an estimated $3.96K and leaving 8,454 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #781.
William Blair & Company first reported a position in LGND in Q3 2013 and has held it in 51 quarters since. The position peaked at $148M in Q2 2015. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- William Blair & Company held 8,454 shares of Ligand Pharmaceuticals worth $1.69M as of Q1 2026.
- William Blair & Company sold 20 Ligand Pharmaceuticals shares in Q1 2026, an estimated $3.96K.
- Ligand Pharmaceuticals made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #781 holding.
- William Blair & Company first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
- William Blair & Company's Ligand Pharmaceuticals position peaked at $148M in Q2 2015.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.